Healthcare revenue cycle management company Aspirion appointed Scott Doolittle CFO, effective April 1.
Mr. Doolittle previously served as CFO of Quantum Health, where he led significant financial growth through a combination of strategic mergers and acquisitions and organic growth initiatives.
The appointment comes less than five months after Nick Giannasi took over as Aspirion CEO. Mr. Giannasi succeeded Amy Amick, who moved to the Aspirion’s board in November. She had served as CEO since April 2023.
“In Scott, we’ve found a financial strategist who understands the economic realities facing hospital CFOs and revenue cycle leaders today,” Mr. Giannasi said in an April 1 news release. “His experience scaling healthcare technology companies through private equity partnerships directly mirrors Aspirion’s trajectory.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
